APPLICATION
ANDA201750
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-11
LATEST ACTION
2017-07-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ULTACAN FORTEDiscontinued
ARTICAINE HYDROCHLORIDE 4%, EPINEPHRINE BITARTRATE EQ 0.017MG BASE/1.7ML (4% · INJECTABLE · INJECTION
Approval history
2017-07-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.